Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
SVRA · NASDAQ · Pharmaceutical Preparations
$4.26−0.95 (−18.23%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Savara (SVRA) · oqro.io/stocks/SVRA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Polar Capital Holdings Plc now owns 5.6% of SVRA as a passive investorSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in SVRA for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Longaeva Partners L.P. disclosed a reduced position in SVRA for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC no longer reported SVRA for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Longaeva Partners L.P. disclosed an increased position in SVRA for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Frazier Life Sciences Management, L.P. disclosed a reduced position in SVRA for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Longaeva Partners L.P. disclosed a new position in SVRA for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
RTW Investments, LP disclosed a new position in SVRA for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed a new position in SVRA for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Deerfield Management Company, L.P. disclosed an increased position in SVRA for Q4 2025Insider trade · Traded Jun 20, 2025 · Filed Jun 23, 2025
Director purchased ~$99K of SVRA shares in the open marketSourceInsider trade · Traded May 29, 2025 · Filed Jun 2, 2025
Director purchased ~$21K of SVRA shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in SVRA for Q1 2025SourceInsider trade · Traded Mar 31, 2025 · Filed Apr 1, 2025
Director purchased ~$416K of SVRA shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 18, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in SVRA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deerfield Management Company, L.P. disclosed an increased position in SVRA for Q4 2024SourceInsider trade · Traded Dec 16, 2024 · Filed Dec 16, 2024
CEO sold ~$181K of SVRA shares in the open marketSourceInsider trade · Traded Dec 16, 2024 · Filed Dec 16, 2024
CFO sold ~$83K of SVRA shares in the open marketSourceInsider trade · Traded Dec 16, 2024 · Filed Dec 16, 2024
Director sold ~$27K of SVRA shares in the open marketSourceInsider trade · Traded Nov 19, 2024 · Filed Nov 20, 2024
Director purchased ~$59K of SVRA shares in the open marketSourceInsider trade · Traded Nov 18, 2024 · Filed Nov 18, 2024
Director purchased ~$288K of SVRA shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deerfield Management Company, L.P. disclosed a new position in SVRA for Q3 2024SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Frazier Life Sciences Management, L.P. disclosed a reduced position in SVRA for Q4 2025Source